TY - JOUR T1 - Hypophosphatasia: Clinical manifestations, diagnostic recommendations and therapeutic options JO - Anales de Pediatría (English Edition) T2 - AU - Martos-Moreno,Gabriel Ángel AU - Calzada,Joan AU - Couce,María L. AU - Argente,Jesús SN - 23412879 M3 - 10.1016/j.anpede.2017.06.006 DO - 10.1016/j.anpede.2017.06.006 UR - https://analesdepediatria.org/en-hypophosphatasia-clinical-manifestations-diagnostic-recommendations-articulo-S2341287918300668 AB - Hypophosphatasia is a very rare bone metabolism disorder caused by a deficiency in alkaline phosphatase activity, due to mutations in the ALPL gene. Its clinical hallmark is the impairment of skeletal and tooth mineralization, although extra-skeletal manifestations are frequent. Its phenotypic spectrum is widely variable from a subtype with exclusive odontological impairment (odontohypophosphatasia) to five subtypes with systemic involvement, classified according to the age at the onset of the first symptoms (four of them in the paediatric age range: perinatal lethal, perinatal benign, infant and childhood hypophosphatasia). Those subtypes of hypophosphatasia with an earliest onset usually involve a worse prognosis, due to the risk of developing potentially lethal complications, such as seizures or severe respiratory insufficiency, secondary to rib cage malformations. Due to the extremely low prevalence of the severe forms of hypophosphatasia, its clinical variability and overlapping phenotypic features with several more prevalent conditions, the diagnosis of hypophosphatasia in the clinical setting is challenging. However, its potential lethality and impact on the patient's quality of life, along with the recent availability of an enzyme replacement therapy, increases the relevance of the early and accurate identification of patients affected with hypophosphatasia. On the basis of published evidence and clinical experience, this article suggests an algorithm with practical recommendations for the differential diagnosis of childhood hypophosphatasia, as well as an updated review of current therapeutic options. ER -